Suresh K. Durgam - Net Worth and Insider Trading
Suresh K. Durgam Net Worth
The estimated net worth of Suresh K. Durgam is at least $3 Million dollars as of 2025-05-07. Suresh K. Durgam is the EVP, Chief Medical Officer of Intra-Cellular Therapies Inc and owns about 19,803 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $3 Million. Details can be seen in Suresh K. Durgam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Suresh K. Durgam has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Suresh K. Durgam
Suresh K. Durgam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Suresh K. Durgam owns 1 companies in total, including Intra-Cellular Therapies Inc (ITCI) .
Click here to see the complete history of Suresh K. Durgam’s form 4 insider trades.
Insider Ownership Summary of Suresh K. Durgam
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-03-11 | Chief Medical Officer |
Suresh K. Durgam Latest Holdings Summary
Suresh K. Durgam currently owns a total of 1 stock. Suresh K. Durgam owns 19,803 shares of Intra-Cellular Therapies Inc (ITCI) as of March 11, 2024, with a value of $3 Million.
Latest Holdings of Suresh K. Durgam
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2024-03-11 | 19,803 | 131.87 | 2,611,422 |
Holding Weightings of Suresh K. Durgam
Suresh K. Durgam Form 4 Trading Tracker
According to the SEC Form 4 filings, Suresh K. Durgam has made a total of 16 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 10,162 shares on March 11, 2024, which brought Suresh K. Durgam around $672,826.
Insider Trading History of Suresh K. Durgam
- 1
Suresh K. Durgam Trading Performance
Suresh K. Durgam Ownership Network
Ownership Network List of Suresh K. Durgam
Ownership Network Relation of Suresh K. Durgam
Suresh K. Durgam's Compensation Overview
| Company | Year | Salary($) | Bonus($) | Stock Awards($) | Option Awards($) | Equity Awards($) | Non-Equity Incentive Plan($) | All Other Compensation($) | Change in Pension and Deferred Comp($) | Total($) |
|---|---|---|---|---|---|---|---|---|---|---|
 | | | | | | | | | | |
Suresh K. Durgam Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Suresh K. Durgam is the Chief Medical Officer of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , SVP and General Counsel Michael Halstead , and EVP & Chief Commercial Officer Mark Neumann .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Suresh K. Durgam made 5 insider transaction in Intra-Cellular Therapies Inc (ITCI) with a net sale of 103,985. Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 698,809 shares made by Sharon Mates , a net sale of 181,827 shares made by Michael Halstead , and a net sale of 58,958 shares made by Mark Neumann .
In summary, during the past 3 months, insiders sold 0 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,162,142 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,162,142 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Suresh K. Durgam Mailing Address
Above is the net worth, insider trading, and ownership report for Suresh K. Durgam. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Suresh K. Durgam's mailing address is: New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
